Matthew J Frigault

9PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 31, 2025
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatment.

Viktoria Blumenberg, Benjamin R Puliafito, Charlotte E Graham

|May 09, 2024
Stealth transgenes enable CAR-T cells to evade host immune responses.

Korneel Grauwet, Trisha Berger, Michael C Kann

|Dec 22, 2022
Dose-response correlation for CAR-T cells: a systematic review of clinical studies.

Anand Rotte, Matthew J Frigault, Ayub Ansari

|Sep 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma.

Nicholas J Haradhvala, Mark B Leick, Katie Maurer

|Apr 25, 2022
Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma.

Matthew J Frigault, Michael R Bishop, Jacalyn Rosenblatt

|Feb 15, 2022
Safety and efficacy of tisagenlecleucel in primary CNS lymphoma: a phase 1/2 clinical trial.

Matthew J Frigault, Jorg Dietrich, Kathleen Gallagher

Pageof 2

Frequent Collaborators

7 joint publications

Marcela V Maus

3 joint publications

Mark Leick

3 joint publications

Zachariah DeFilipp

2 joint publications

Yi-Bin Chen